Atishay Limited
ATISHAY (BSE 538713) · ISIN INE011R01013 · Software Products · Est. 2000 · listed 2014 · website
Not on any surveillance list
Next: Board meeting: financial results on 3 November 2026.
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹55.08 cr | ₹5.32 cr | ₹63.41 cr |
| 30 Sep 2025 standalone | ₹51.16 cr | ₹4.76 cr | ₹63.06 cr |
| 31 Mar 2025 standalone | ₹48.6 cr | ₹4.41 cr | ₹58.4 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 74.65% | — | — | 25.35% |
Latest filings
- Board of Directors of Atishay Limited, at its meeting held today, i.e, July 16, 2026, has, inter alia, considered & approved the Un-Audited Ind AS Standalone Financial Results of the Company .... 16 July 2026 · BSE
- Board of Directors of Atishay Limited, at its meeting held today, i.e., July 16, 2026, has, inter alia, considered & approved the following matters: 1. The Un-Audited Ind AS Standalone .... 16 July 2026 · BSE
- Submission of proceedings of the 26th Annual General Meeting of the Company, Voting Results along with Scrutiniser Report. 26 May 2026 · BSE
- Submission of Proceedings of the 26th Annual General Meeting, voting results along with Scrutinizer report. 26 May 2026 · BSE
- Notice convening 26th Annual General Meeting of the Company to be held on Tuesday, May 26, 2026 at 12.30 PM through Video Conferencing and/or other Audio-Visual means. 4 May 2026 · BSE
Other companies in Software Products
- Oracle Financial Services Software Limited
- Tanla Platforms Limited
- Nucleus Software Exports Limited
- C.E. Info Systems Limited
- Ramco Systems Limited
- Subex Limited
- Quick Heal Technologies Limited
- Capillary Technologies India Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.